Extreme Short Interest Swings
Short Interest Swings Reach 2,237% Across Multiple Securities and Stocks
Anonymous
September short-interest updates showed sharply different moves among the reported securities. Black Hawk Acquisition’s BKHAR shares saw short interest jump 2,236.8% to 444 shares by Sept. 15, up from 19 shares at the end of August; two reports carried the same figures. Short interest fell 88.5% at SAB Biotherapeutics’ SABSW to 765 shares, 84.9% at Black Spade Acquisition III to 1,562 shares, and 83.2% at Black Hawk Acquisition’s separate BKHA ticker to 53 shares. Each update reported a days-to-cover ratio of 0.5 or less, reflecting the small short positions relative to reported trading volumes.
Key Points
1
SAB Biotherapeutics is a clinical-stage biopharmaceutical company developing fully human polyclonal antibody treatments using genetically engineered cattle; its lead programs target emerging coronaviruses and other viral threats.
2
Black Spade Acquisition III is a SPAC without operating products or commercial services; its future business and geographic focus depend on a transaction it has yet to complete. MarketBeat reported one analyst rating the stock Sell and a consensus rating of Sell.
3
Black Hawk Acquisition’s separate BKHA ticker reported quarterly earnings of $0.02 per share on July 15; Weiss Ratings reiterated a “sell (d)” rating, and the article said the analyst consensus was Sell.
4
Black Hawk Acquisition says it is seeking a business combination, with technology, digital media and consumer products among the industries it may target. The company completed its Nasdaq IPO in 2021, raising about $250 million in gross proceeds.
Sentiment
Mostly NegativeNEGATIVENEUTRALPOSITIVE
Publishers
19
Articles
19
Reach
38
A
AnonymousAuthor
